≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Tonsil

DOID Endpoint Browser PheWeb

CD2_BENIGN_TONSIL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D10.4&
  • Hospital discharge: ICD-9 — 2105
  • Hospital discharge: ICD-8 — 2105
  • Cause of death: ICD-10 — D10.4&
  • Cause of death: ICD-9 — 2105
  • Cause of death: ICD-8 — 2105

2 out of 7 registries used, show all original rules.

415

4. Check minimum number of events

None

415

5. Include endpoints

None

415

6. Filter based on genotype QC (FinnGen only)

415

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10
Name in latin
Neoplasma benignum tonsillae palatinae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2787 1600 1173
Only index persons 2614 1535 1079
Unadjusted period prevalence (%)
Whole population 0.04 0.05 0.03
Only index persons 0.05 0.06 0.04
Median age at first event (years)
Whole population 56.41 55.74 57.29
Only index persons 55.84 55.41 56.47

-FinnGen-

Key figures

All Female Male
Number of individuals 415 245 170
Unadjusted period prevalence (%) 0.08 0.08 0.07
Median age at first event (years) 59.35 56.63 63.26

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
367
Matched controls
3668
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
+∞
323.0
353
*
EMA10
NOMESCO Finland
Biopsy of tonsil
420.5
70.1
68
*
EMB10
NOMESCO Finland
Tonsillectomy
11.8
41.0
79
83
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
157.6
40.7
42
*
C09.9
ICD-10 Finland
Malignant neoplasm: Tonsil, unspecified
198.9
35.4
36
*
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
90.5
30.3
33
*
ENA10
NOMESCO Finland
Biopsy of pharynx
62.2
29.7
34
6
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
24.0
24.8
35
16
JDB10
NOMESCO Finland
Percutaneous gastrostomy
28.1
23.1
31
12
130
Kela drug reimbursment
Malignant tumour
5.3
20.7
67
148
C09.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tonsil
199.8
18.7
19
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.7
18.6
56
113
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.1
18.6
52
96
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
42.2
16.5
20
5
WF002
NOMESCO Finland
Radical radiotherapy
5.7
16.0
47
92
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
15.6
109
458
J35.1
ICD-10 Finland
Hypertrophy of tonsils
14.3
13.9
23
17
8070/3-C09.0
ICD-O-3
Squamous cell carcinoma, NOS, of tonsillar fossa
+∞
13.6
13
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
17.5
13.1
20
12
ZXE00
NOMESCO Finland
One hour or less
2.3
12.4
170
1012
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.2
11.8
46
122
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.2
11.7
36
75
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
11.6
167
1006
EMB00
NOMESCO Finland
Excision of lesion of tonsil or adenoids
123.7
11.5
12
*
R07.0
ICD-10 Finland
Pain in throat
4.5
11.5
41
100
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
20.8
11.2
16
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
10.7
137
774
UJC01
NOMESCO Finland
Scopy of lower throat
14.2
9.3
15
11
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.9
9.1
29
63
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.6
9.0
30
69
A04AA02
ATC
granisetron; systemic, transdermal
3.7
8.9
39
115
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.6
8.8
30
70
N02AA05
ATC
oxycodone; systemic
2.5
8.7
72
326
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
8.4
8
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
7.1
8.2
19
28
H02AB02
ATC
dexamethasone; systemic
2.9
8.2
50
188
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
8.0
120
710
R21
ICPC
Throat symptom/complaint
2.3
7.9
80
399
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
15.4
7.8
12
8
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
7.7
156
1028
J39.2
ICD-10 Finland
Other diseases of pharynx
12.2
7.6
13
11
ZX095
NOMESCO Finland
Combined chemoradiotherapy
10.3
7.6
14
14
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
6.7
7.5
18
28
EHA10
NOMESCO Finland
Biopsy of palate
13.7
7.4
12
9
XX3DW
NOMESCO Finland
Time consuming IT work
2.7
7.4
50
201
21050
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Tonsil
+∞
7.3
7
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
8.2
7.2
15
19
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.9
6.7
42
159
Z2221
NOMESCO Finland
Medical doctor
1.9
6.7
107
641
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
12.6
6.6
11
9
WX110
NOMESCO Finland
Local anesthesy
1.8
6.5
251
2003
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
71.0
6.4
7
*
N02BE01
ATC
paracetamol; systemic, rectal
2.1
6.4
315
2732
SXC03
NOMESCO Finland
Other oral or dental procedure
11.3
6.3
11
10
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
18.4
6.3
9
5
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
+∞
6.3
6
*
J35.8
ICD-10 Finland
Other chronic diseases of tonsils and adenoids
+∞
6.3
6
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
6.3
6
*
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
6.3
6
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
5.9
6.2
16
28
A07AA02
ATC
nystatin; oral
3.1
6.2
33
115
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.0
6.2
23
60

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
257
1405
3.18
28.78
2.5
2.1
—
—
—
0
0
(4035726)
98
316
3.75
26.14
1.7
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
130
589
2.76
18.90
1.6
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
39
87
4.84
16.72
1.3
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
25
37
7.13
16.32
1.2
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
120
563
2.59
15.93
4.5
3.2
mmol/l
0.8
0.8
0.82
112
532
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
20
26
8.03
14.54
1.3
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
185
1163
2.07
11.57
4.5
3.3
mmol/l
2.4
2.4
1.16
162
1022
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
239
1685
1.99
10.47
5.5
6.4
mmol/l
1.2
1.2
0.27
197
1423
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
331
2680
2.16
9.16
9.5
7.5
u/l
76.2
77.8
0.39
321
2512
(3013650) Neutrophils [#/volume] in Blood by Automated count
265
2005
1.89
8.67
12.4
9.4
e9/l
4.0
4.1
0.41
232
1781
(3024561) Albumin [Mass/volume] in Serum or Plasma
206
1448
1.84
8.45
5.1
4.5
g/l
35.9
35.6
0.38
200
1351
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
246
1827
1.85
8.44
7.1
6.2
umol/l
10.2
11.2
1.37
239
1735
(42870588) Differential panel, method unspecified - Blood
169
1125
1.85
8.21
6.4
5.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
213
1551
1.77
7.45
4.8
5.5
mmol/l
1.2
1.2
0.13
199
1417
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
119
734
1.87
7.20
1.3
1.3
u/ml
0.6
2.0
1.63
29
208
(3021589) Normoblasts [#/volume] in Blood
209
1534
1.73
6.94
11.3
9.5
e9/l
0.0
0.0
0.45
174
1268
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
106
639
1.88
6.85
3.9
3.0
mmol/l
2.5
2.5
0.38
94
553
(3002256) Pathology report gross observation
80
441
2.01
6.71
1.3
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
220
1653
1.70
6.59
7.8
6.0
%
27.0
28.1
0.68
208
1555
(3019069) Monocytes/100 leukocytes in Blood
216
1616
1.70
6.57
7.8
6.1
%
9.0
8.6
0.64
206
1524
(3018010) Neutrophils/100 leukocytes in Blood
217
1632
1.69
6.42
7.5
5.8
%
57.7
57.0
0.31
207
1539
(3001604) Monocytes [#/volume] in Blood
226
1721
1.69
6.35
7.5
5.8
e9/l
0.6
0.6
0.63
199
1504
(3019198) Lymphocytes [#/volume] in Blood
231
1770
1.69
6.34
7.8
5.8
e9/l
1.8
1.9
0.92
206
1580
(3007164) IgA [Mass/volume] in Serum or Plasma
107
662
1.83
6.32
1.5
1.6
g/l
2.2
2.5
0.71
61
411
(3006315) Basophils [#/volume] in Blood
226
1732
1.67
6.11
7.7
5.8
e9/l
0.0
0.0
0.18
198
1515
(3006504) Eosinophils/100 leukocytes in Blood
213
1609
1.67
6.08
7.7
5.9
%
2.6
2.8
0.44
202
1508
(3013115) Eosinophils [#/volume] in Blood
231
1782
1.67
6.07
7.7
6.0
e9/l
0.2
0.2
1.28
206
1589
(3022096) Basophils/100 leukocytes in Blood
206
1555
1.64
5.81
7.9
5.9
%
0.7
0.7
0.21
195
1457
(3026389) Candida sp identified in Specimen by Organism specific culture
14
34
4.23
5.40
1.5
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
307
2594
1.71
5.32
4.8
4.1
mm/h
12.5
11.8
0.37
286
2381
(3018418) pH of Serum or Plasma
148
1045
1.65
5.32
4.4
3.7
ph
7.4
7.4
0.76
34
196
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
313
2671
1.70
5.09
5.1
3.9
pmol/l
14.6
14.8
0.44
293
2433
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
361
3214
1.95
5.04
6.0
4.7
mu/l
2.0
2.3
0.36
337
2944
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
368
3298
2.02
5.03
18.0
12.7
ml/min/173m2
80.9
81.1
0.07
324
2700
(3019550) Sodium [Moles/volume] in Serum or Plasma
389
3563
2.46
4.99
19.5
15.8
mmol/l
139.6
139.7
0.47
380
3469
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
57
309
1.98
4.97
2.8
2.4
u/l
30.8
34.5
0.38
50
261
(3030467) Casts [#/volume] in Urine by Automated count
132
919
1.64
4.96
3.4
3.0
e6/l
0.3
0.4
0.67
98
693
(3023103) Potassium [Moles/volume] in Serum or Plasma
389
3572
2.42
4.80
19.8
15.9
mmol/l
4.0
4.0
1.09
380
3475
(3044889) 12 lead EKG panel
291
2460
1.61
4.67
4.4
3.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
47
245
2.04
4.57
1.3
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
86
548
1.72
4.47
2.8
2.7
e6/l
1.1
1.0
0.08
48
313
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
518
1.73
4.40
3.3
2.8
e6/l
1.9
2.3
0.24
45
287
(36304419) Bacteria [Presence] in Urine
127
902
1.59
4.31
3.4
2.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
6
11.84
4.29
1.1
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
159
1192
1.54
4.24
4.3
3.6
e6/l
134.7
85.1
0.27
113
843
(3002582) Erythrocytes [#/volume] in Urine
138
1005
1.56
4.18
3.7
3.0
e6/l
31.6
132.2
0.86
105
775
(3003458) Phosphate [Moles/volume] in Serum or Plasma
70
432
1.75
4.07
5.8
4.9
mmol/l
1.0
1.0
0.05
62
403
(3026493) Urate [Moles/volume] in Serum or Plasma
125
895
1.57
4.07
3.2
2.5
umol/l
6858.8
7447.4
0.04
111
765
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
7
10.14
4.02
1.1
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
65
394
1.77
4.01
2.2
2.4
ug/g
88.1
151.7
1.81
44
310
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
211
1.99
3.78
1.3
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
50
3.08
3.72
2.5
3.8
—
3883.9
—
0
7
(3022145) Colonoscopy Study observation
65
403
1.73
3.71
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
34
170
2.09
3.71
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
111
2.33
3.62
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
45
252
1.88
3.59
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
176
1387
1.47
3.54
2.0
2.0
pmol/l
100.5
96.4
0.49
92
697
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
375
3461
1.87
3.53
19.1
13.7
mg/l
20.1
22.5
0.88
322
2743
(40768443) Skin Pathology biopsy report
30
146
2.14
3.51
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
113
2.29
3.49
1.1
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
18
5.09
3.39
1.7
2.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
155
1202
1.46
3.34
3.8
3.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
119
876
1.50
3.33
8.4
6.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
269
2321
1.45
3.23
3.2
3.1
u/l
48.8
49.7
0.05
251
2182
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
367
3384
1.73
3.22
4.9
4.5
mmol/l
5.9
6.0
0.49
339
3101
(3025941) Bacteria identified in Stool by Culture
35
187
1.95
3.21
1.3
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
95
672
1.54
3.19
3.1
2.5
mosm/kgh2o
513.9
567.3
1.50
79
563
(40768797) Stomach Pathology biopsy report
74
494
1.61
3.19
1.3
1.2
—
—
—
0
0
(3013512) EKG study
135
1031
1.46
3.12
3.9
3.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
61
390
1.66
3.12
1.8
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
52
319
1.72
3.09
2.8
2.0
nmol/l
392.2
369.2
0.40
47
292
(3023368) Bacteria identified in Blood by Culture
119
891
1.47
3.03
4.8
4.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
174
1403
1.41
2.96
2.4
2.2
nmol/l
76.3
77.8
0.24
149
1249
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
77
529
1.56
2.94
2.1
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
345
3151
1.56
2.93
18.4
14.3
%
39.9
40.0
0.13
239
2279
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
231
1.81
2.92
1.3
1.2
iu/ml
83.6
132.6
0.65
15
98
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
67
447
1.59
2.89
2.0
2.1
%
23.3
23.2
0.02
58
393
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
108
800
1.47
2.89
2.3
2.0
mg/l
3.4
3.2
0.16
91
692
(3017181) Myelocytes/100 leukocytes in Blood
48
294
1.72
2.88
6.8
4.5
%
1.0
0.8
0.21
20
96
(3013290) Carbon dioxide [Partial pressure] in Blood
17
71
2.45
2.84
1.7
3.2
kpa
5.1
5.1
0.08
17
71
(3027315) Oxygen [Partial pressure] in Blood
17
71
2.45
2.84
1.7
3.2
kpa
8.4
8.7
0.26
17
71
(3000850) Epithelial cells [#/volume] in Urine
96
699
1.49
2.79
2.7
2.4
e6/l
6.0
6.1
0.03
83
615
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
23
3.98
2.79
2.8
3.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
111
2.13
2.78
1.1
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
238
2039
1.39
2.77
4.3
4.5
mmol/l
6.4
6.7
2.36
231
1898
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
40
235
1.78
2.77
1.8
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
45
275
1.71
2.72
7.0
4.7
%
0.0
0.1
2.18
17
86
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
59
388
1.61
2.71
3.1
2.6
umol/l
5.1
8.4
2.79
52
346
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
66
449
1.56
2.63
1.4
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
53
342
1.63
2.62
3.8
3.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
390
3701
1.89
2.52
13.3
10.4
u/l
26.8
26.0
0.41
382
3572
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
32
181
1.83
2.52
4.1
9.2
mmol/l
23.9
24.6
0.82
32
170
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
30
167
1.86
2.48
2.5
2.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
30
168
1.85
2.44
1.1
1.1
—
88.5
—
0
6
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
98
736
1.43
2.41
1.7
1.7
mg/l
0.8
1.2
2.19
73
587
(40761536) Microorganisms panel - Urine sediment
45
285
1.65
2.40
3.6
3.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
136
1085
1.38
2.36
2.5
2.4
u/l
54.2
57.4
0.65
125
1019
(3017143) Hepatitis C virus Ab [Presence] in Serum
54
360
1.57
2.35
1.5
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
55
370
1.56
2.31
3.2
2.6
%
1.6
1.8
0.94
48
336
(3004789) Transferrin [Mass/volume] in Serum or Plasma
67
476
1.49
2.19
1.9
2.1
g/l
2.4
2.4
0.39
59
441
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
27
152
1.83
2.18
1.1
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
54
367
1.54
2.17
1.9
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
373
3521
1.59
2.15
5.0
5.0
mmol/l
2.8
2.8
0.48
337
3236
(40767503) Oxygen content in Capillary blood by calculation
14
62
2.30
2.10
1.6
2.6
%
14.5
16.0
—
6
23
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
185
1572
1.32
2.06
4.5
4.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
111
1.94
2.05
1.6
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
50
2.44
2.04
2.0
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
84
632
1.41
2.04
4.7
3.6
ng/l
310.2
194.7
0.29
68
493
(1616796) Gas panel - Central venous blood
14
63
2.26
2.03
1.6
2.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
44
2.54
2.02
1.5
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
10
38
2.67
2.02
2.1
1.9
ug/l
12.1
17.6
—
10
38
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
59
416
1.49
2.01
1.8
1.8
%
1.5
1.5
0.19
46
363
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
70
2.19
2.00
1.1
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
366
3451
1.51
2.00
4.5
4.5
mmol/l
4.7
4.7
0.06
328
3191
(3010421) pH of Blood
17
84
2.07
1.98
1.7
3.1
ph
7.4
7.4
0.26
17
71
(3000494) Fungus identified in Specimen by Culture
60
426
1.48
1.98
1.5
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
71
521
1.44
1.98
1.9
2.1
umol/l
13.7
13.6
0.04
63
481
(40760892) CBC W Ordered Manual Differential panel - Blood
102
798
1.37
1.96
6.8
4.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
32
196
1.69
1.96
1.4
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
177
1504
1.31
1.94
2.9
2.5
ug/l
141.8
123.2
0.41
164
1386
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
16
3.79
1.94
1.0
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
39
2.60
1.93
1.5
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
24
136
1.81
1.91
1.3
2.2
g/l
1.4
1.5
0.50
17
117
(3032080) INR in Blood by Coagulation assay
165
1392
1.31
1.90
6.6
7.9
inr
1.1
1.2
0.41
58
394
(3007461) Platelets [#/volume] in Blood
398
3838
1.90
1.87
27.5
20.3
e9/l
253.2
249.4
0.52
389
3745
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
52
363
1.49
1.87
1.7
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
265
2385
1.31
1.86
5.1
4.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
66
2.16
1.84
1.6
2.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
398
3840
1.89
1.83
27.4
20.2
fl
91.2
91.1
0.12
393
3784
(3035941) MCH [Entitic mass]
398
3840
1.89
1.83
27.4
20.2
pg
30.3
30.3
0.24
393
3783
(3013727) Leukocytes other/100 leukocytes in Blood
5
12
4.20
1.83
3.2
4.6
%
59.1
51.7
—
5
12
(3010813) Leukocytes [#/volume] in Blood
398
3841
1.88
1.82
27.5
20.3
e9/l
6.7
6.6
0.10
389
3739
(3026361) Erythrocytes [#/volume] in Blood
398
3841
1.88
1.82
27.4
20.3
e12/l
4.5
4.5
0.73
388
3740
(3011412) CD3 cells [#/volume] in Blood
8
29
2.79
1.80
1.3
1.9
e9/l
1.1
0.8
—
8
13
(3026008) Bacteria identified in Urine by Culture
125
1022
1.32
1.79
3.0
3.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
71
531
1.41
1.79
1.7
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
132
1088
1.31
1.78
2.8
2.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
84
647
1.37
1.78
1.9
1.7
nmol/l
1086.6
1212.8
0.63
64
484
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
30
186
1.66
1.78
1.9
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
41
275
1.54
1.77
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
68
2.10
1.72
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
68
2.10
1.72
1.2
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
11
48
2.33
1.72
1.5
1.2
nmol/l
0.6
0.5
0.15
11
43
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
62
2.13
1.67
2.1
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
76
2.01
1.66
1.1
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
24
143
1.72
1.65
2.8
3.0
mmol/l
24.6
24.4
0.19
19
133
(3002179) Metamyelocytes/100 leukocytes in Blood
39
264
1.53
1.63
6.6
4.5
%
0.5
0.5
0.13
11
70
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
14
3.60
1.62
1.2
2.4
%
110.8
93.9
—
5
14
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
84
1.94
1.62
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
21
345
0.59
1.59
1.3
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
312
2897
1.31
1.59
23.5
16.6
%
14.0
13.7
1.74
301
2846
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
40
275
1.50
1.56
4.4
2.5
ml/min/173m2
66.7
65.9
0.06
23
113
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
115
1.78
1.55
1.6
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
397
3844
1.76
1.55
27.7
20.4
g/l
134.1
135.5
1.17
392
3786
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
33
2.45
1.54
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
93
1.86
1.54
1.1
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
42
0.00
1.53
0.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
19
108
1.80
1.53
1.5
1.3
—
1.2
—
0
5
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
44
0.00
1.52
0.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
101
1.82
1.51
1.3
1.4
ug/g
305.2
301.5
0.02
11
58
(40761511) CBC panel - Blood by Automated count
378
3623
1.49
1.51
16.0
12.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
38
261
1.50
1.50
7.8
4.7
%
0.0
0.0
0.80
13
75
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
37
2.46
1.48
2.4
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
192
1692
1.25
1.46
3.6
3.5
estimate
0.0
0.0
0.00
43
320
(40768441) Liver Pathology biopsy report
7
28
2.52
1.46
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
46
2.20
1.41
1.3
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
193
1711
1.24
1.37
4.8
4.7
estimate
0.0
0.0
0.00
43
321
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
97
1.78
1.37
1.4
1.2
—
—
—
0
0
(3000492) Spirometry study
44
318
1.43
1.36
1.4
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
68
1.94
1.35
3.2
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
54
2.07
1.34
1.2
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
61
469
1.35
1.32
1.6
1.3
titre
404.4
497.2
0.27
18
116
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
24
2.52
1.31
1.3
3.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
84
1.82
1.28
1.9
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
194
1730
1.23
1.28
3.7
3.5
estimate
0.0
0.0
0.50
44
310
(3036489) Thrombin time
19
115
1.68
1.27
1.2
2.0
s
26.1
22.0
0.33
19
103
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
63
1.93
1.24
3.5
3.7
%
55.0
59.4
0.37
12
63
(3000991) Gas panel - Venous blood
37
264
1.44
1.24
4.9
7.9
—
—
—
0
0
(44790049)
8
37
2.18
1.22
1.6
1.6
—
—
—
0
0
(44790047)
8
37
2.18
1.22
1.6
1.6
—
—
—
0
0
(44806118)
8
37
2.18
1.22
1.6
1.6
—
—
—
0
0
(44790048)
8
37
2.18
1.22
1.6
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
86
1.77
1.20
1.6
1.9
u/l
1418.5
2271.8
—
6
29
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
86
1.77
1.20
1.9
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
348
3317
1.30
1.19
4.1
4.0
mmol/l
1.3
1.3
0.03
309
3042
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
26
2.33
1.19
1.8
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
38
2.13
1.19
2.0
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
88
724
1.27
1.18
1.8
1.7
pmol/l
456.9
437.0
0.22
72
599
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
98
817
1.26
1.18
2.5
2.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
35
250
1.44
1.17
2.9
3.1
ng/l
75.3
74.9
0.02
30
220
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
39
2.07
1.16
1.3
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
35
0.00
1.15
0.0
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
21
135
1.59
1.13
1.4
1.3
—
2.2
—
0
9
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
48
365
1.36
1.13
3.5
4.4
ug/l
13.0
19.2
0.21
38
307
(3022217) INR in Platelet poor plasma by Coagulation assay
55
428
1.33
1.12
14.1
19.8
inr
1.1
1.3
—
7
60
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
358
3433
1.31
1.11
4.5
4.5
mmol/l
1.5
1.5
0.77
316
3157
(3002523) Influenza virus A Ag [Presence] in Specimen
11
59
1.89
1.08
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
59
1.89
1.08
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
75
613
1.27
1.07
1.4
1.3
iu/ml
20.4
38.2
1.91
15
207
(3019225) pH of Specimen
42
318
1.36
1.03
2.7
4.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
35
2.02
1.00
2.1
2.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
49
1.85
0.99
1.2
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
23
2.19
0.98
1.0
1.3
%
9.0
11.1
—
5
23
(3010726) Horse dander IgE Ab [Units/volume] in Serum
7
36
1.96
0.97
1.0
1.1
—
0.2
—
0
5
(3037756) Immunofixation for Serum or Plasma
13
77
1.71
0.96
1.5
1.7
—
—
—
0
0
(4034850)
6
117
0.51
0.95
6.0
9.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
96
819
1.22
0.95
1.5
1.5
nmol/l
18.4
21.3
1.44
80
690
(3003694) ABO and Rh group [Type] in Blood
104
895
1.22
0.94
1.5
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
150
1337
1.19
0.94
3.7
3.6
ng/l
29.9
63.7
0.67
94
923
(3011397) Hemoglobin [Presence] in Urine by Test strip
91
773
1.23
0.94
3.4
3.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
28
2.16
0.92
3.0
2.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
64
527
1.25
0.87
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
30
222
1.38
0.86
2.8
2.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
44
1.83
0.86
1.6
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
137
1.48
0.85
2.8
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
60
492
1.26
0.85
1.8
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
33
1.83
0.79
1.3
1.2
—
94.4
—
0
5
(3029937) Albumin [Presence] in Urine by Test strip
104
912
1.19
0.77
4.0
3.8
estimate
0.0
0.0
0.00
43
313
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.2
—
65.3
—
0
8
(3004588) Protein electrophoresis panel - Serum or Plasma
31
236
1.34
0.76
2.8
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
32
245
1.33
0.76
1.5
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
38
299
1.30
0.75
2.9
3.0
mmol/l
2.1
2.2
0.12
29
231
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
24
2.10
0.74
1.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
38
1.86
0.74
1.7
2.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
108
957
1.17
0.71
1.5
1.7
mmol/l
1.3
1.4
0.17
86
813
(3021447) Carbon dioxide [Partial pressure] in Venous blood
38
302
1.28
0.71
2.8
3.0
kpa
5.9
5.8
0.28
33
292
(3025130) Human papilloma virus identified in Specimen
7
41
1.72
0.70
2.0
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
31
240
1.32
0.70
1.6
2.1
nmol/l
12.9
13.4
0.11
24
214
(3023520) Reticulocytes [#/volume] in Blood
33
258
1.30
0.69
3.2
2.7
e9/l
59.1
73.6
1.09
23
198
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
61
1.66
0.69
3.2
3.3
e9/l
3.9
4.8
—
10
61
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
42
1.68
0.68
1.7
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
27
1.86
0.68
3.6
2.0
—
774.0
—
0
11
(3051651) Icteric interference index of Serum or Plasma
5
27
1.86
0.68
2.2
2.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
43
1.64
0.67
1.7
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
2.6
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
28
1.80
0.66
3.4
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
28
1.80
0.66
1.0
1.0
—
0.0
—
0
6
(3023430) Cat dander IgE Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.1
—
1.1
—
0
10
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
17
121
1.42
0.63
1.4
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
63
1.60
0.62
2.4
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
50
1.61
0.61
1.6
2.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
80
1.51
0.60
1.7
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
52
1.55
0.59
2.0
1.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
10
64
1.58
0.59
1.6
2.3
kpa
8.2
8.0
—
10
56
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
112
0.62
0.59
1.0
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
35
1.72
0.58
2.3
2.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
98
1.44
0.57
2.3
3.1
—
—
—
0
0
(4268621)
6
36
1.68
0.57
3.0
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
89
0.56
0.56
2.0
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
32
258
1.26
0.56
2.2
2.4
kpa
4.2
4.4
0.54
27
249
(3037121) Protein [Mass/volume] in Urine
16
116
1.39
0.55
1.8
3.4
g/l
0.1
0.2
—
5
47
(40760888) Immunoglobulin light chains.free panel - Serum
12
82
1.48
0.55
4.9
4.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
67
585
1.17
0.54
1.4
1.3
u/ml
3.6
11.5
1.46
24
235
(3024928) Oxygen saturation in Venous blood
9
64
1.42
0.52
1.4
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
65
1.39
0.51
2.0
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
13
93
1.41
0.48
1.6
1.4
miu/ml
94.9
238.2
—
7
49
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
102
1.39
0.48
1.2
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
112
1026
1.13
0.47
2.5
2.1
u/l
188.6
190.2
0.01
102
961
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
48
1.47
0.47
1.4
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
48
1.47
0.47
1.3
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
48
1.47
0.47
2.3
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
176
0.73
0.47
1.5
1.8
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
16
120
1.35
0.47
1.6
1.8
—
163.3
—
0
6
(3028707) Methadone [Presence] in Urine by Screen method
7
49
1.44
0.46
1.1
1.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
5
84
0.59
0.46
1.0
1.2
e6/l
1.2
14.7
—
5
68
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
84
0.59
0.46
1.2
1.3
e6/l
20.2
1400.4
—
5
71
(3000330) Specific gravity of Urine by Test strip
21
165
1.29
0.46
3.6
3.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
112
1.35
0.45
2.3
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
50
1.41
0.45
1.3
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
142
1326
1.11
0.43
3.6
3.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
56
1.44
0.43
2.1
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
87
1.39
0.42
1.3
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
32
1.57
0.42
1.6
2.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
58
1.39
0.41
1.5
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.1
—
1.3
—
0
11
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
334
3259
1.13
0.41
5.8
5.8
mmol/mol
39.3
39.9
0.74
307
3043
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
15
0.00
0.41
0.0
1.5
—
118729.7
—
0
9
(3003396) Base excess in Arterial blood by calculation
44
381
1.17
0.41
4.0
7.6
mmol/l
0.0
1.3
1.41
38
314
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
16
0.00
0.41
0.0
1.3
—
1.1
—
0
5
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
132
1.30
0.41
2.5
2.0
g/l
5.1
3.8
—
10
97
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
132
1.30
0.41
2.5
2.0
g/l
7.0
7.6
—
10
103
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
132
1.30
0.41
2.5
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
60
1.34
0.40
1.8
1.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
27
224
1.22
0.39
1.4
2.6
e9/l
4.7
4.0
0.75
22
177
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
124
1.30
0.39
1.7
2.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
66
1.37
0.38
1.2
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
25
300
0.82
0.38
1.7
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
17
134
1.28
0.37
2.8
2.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
125
1.29
0.37
2.7
1.8
—
—
—
0
0
(4062490)
5
37
1.36
0.37
1.0
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
71
1.27
0.36
1.3
2.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
41
1.47
0.36
4.0
1.8
pg
35.2
33.0
—
6
41
(3049717) Cytology report of Urine Cyto stain
17
135
1.27
0.36
2.6
2.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
42
1.43
0.35
3.2
3.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
44
1.37
0.34
2.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
19
154
1.24
0.34
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
45
1.34
0.34
1.3
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
45
1.34
0.34
1.3
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
52
1.35
0.31
1.4
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
52
1.35
0.31
2.0
3.0
—
—
—
0
0
(3020891) Body temperature
10
131
0.76
0.31
4.2
5.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
54
1.30
0.30
1.3
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
54
1.30
0.30
1.3
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
54
1.30
0.30
1.3
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
54
1.30
0.30
1.3
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
84
1.32
0.30
1.1
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
56
1.25
0.29
2.1
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
121
1.25
0.29
1.5
3.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
12
94
1.28
0.28
1.1
2.1
%
78.1
88.3
0.71
12
88
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
62
1.30
0.28
1.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
63
1.28
0.28
1.3
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
86
1.29
0.26
1.2
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
57
620
0.91
0.25
2.5
3.0
ug/l
0.7
0.7
0.52
34
411
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
41
369
1.12
0.25
1.6
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
23
198
1.17
0.25
4.0
3.0
mmol/l
3.6
1.9
1.33
15
152
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
124
1.22
0.24
2.7
2.0
g/l
3.1
3.2
—
10
99
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
153
1.18
0.22
1.8
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
92
0.76
0.22
1.6
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
19
220
0.86
0.22
2.7
4.6
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
1453.5
—
0
11
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.1
—
0.8
—
0
6
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
4.4
—
—
—
0
0
(44806420)
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(4198724)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
111
1060
1.06
0.20
3.3
3.1
mmol/l
7.9
7.5
0.46
92
880
(3016879) Cocaine [Presence] in Urine
12
99
1.22
0.20
1.1
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
100
953
1.06
0.19
3.4
3.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
46
425
1.09
0.19
7.0
7.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
53
1.13
0.18
2.3
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
297
2924
1.06
0.17
23.4
17.7
g/l
331.2
332.3
1.13
292
2910
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
68
1.18
0.16
1.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
68
1.18
0.16
1.0
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
439
1.08
0.16
4.1
4.6
%
29.7
31.9
0.72
30
291
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
212
0.89
0.14
1.4
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
104
1004
1.05
0.13
3.1
3.2
mg/l
48.6
319.2
1.31
67
629
(3019150) Specific gravity of Urine by Refractometry
79
757
1.05
0.13
3.5
3.7
kg/l
1.0
1.0
—
10
102
(1761482) Bacteria [#/volume] in Urine by Culture
11
94
1.17
0.13
3.3
4.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
85
1.18
0.12
1.2
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
103
1062
0.96
0.11
4.5
4.0
mg/mmol
5.4
8.0
0.54
65
649
(3000764) Benzodiazepines [Presence] in Urine
12
105
1.15
0.11
1.1
1.4
—
—
—
0
0
(4010399)
28
260
1.08
0.11
1.6
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
216
2126
1.03
0.10
3.4
2.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
102
1050
0.96
0.10
4.1
4.8
ug/l
1.7
2.5
1.07
89
951
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
81
838
0.96
0.10
3.6
4.3
%
22.7
21.4
0.44
44
389
(3027008) Opiates [Presence] in Urine
12
106
1.14
0.10
1.1
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
106
1.14
0.10
1.1
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
106
1.14
0.10
1.1
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
62
0.80
0.08
1.0
1.1
u/l
20.0
16.1
—
5
52
(3022313) Gas panel - Capillary blood
15
164
0.91
0.08
4.6
2.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
75
0.80
0.07
1.0
1.5
nmol/l
0.9
0.9
—
6
64
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
91
0.88
0.07
1.6
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
93
0.86
0.07
1.0
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
24
227
1.06
0.06
1.3
1.3
—
38.4
—
0
16
(3008898) HLA-B27 [Presence]
12
131
0.91
0.05
1.0
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
102
1003
1.02
0.05
2.7
3.1
ng/l
1877.3
1035.3
0.92
84
852
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
170
0.94
0.04
5.1
8.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
28
271
1.04
0.02
3.5
3.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
129
1282
1.01
0.01
2.8
2.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
98
1.02
0.00
1.6
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
11
109
1.01
0.00
3.0
1.6
g/l
0.2
0.2
0.15
11
104
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
111
0.99
0.00
1.7
1.5
—
—
—
0
0
(4094501)
10
95
1.05
0.00
1.2
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
11
115
0.96
0.00
2.9
1.5
g/l
1.2
1.2
0.04
11
110
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
32
316
1.01
0.00
2.4
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
29
286
1.02
0.00
2.1
1.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.5
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
69
1.01
0.00
3.0
3.2
u/ml
66.0
26.6
—
7
69
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.2
—
3084.3
—
0
6
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
13.8
—
0
6
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
37.5
—
0
6
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.0
—
59.4
—
0
6
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
65.2
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
5
51
0.98
0.00
1.0
1.1
—
18.4
—
0
6
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
1.7
—
0
7
(3024471) HLA-A [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
8
0.00
0.00
0.0
5.4
—
25.3
—
0
8
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
11
110
1.00
0.00
4.0
2.0
ug/l
708.8
279.5
0.60
11
103
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.0
—
50.0
—
0
9
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
65
0.92
0.00
1.3
1.3
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_TONSIL and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_TONSIL 1.132 [0.94, 1.37] 0.203
Birth year 0.995 [0.99, 1.0] 0.236

During the follow-up period (1.1.1998 — 31.12.2019), 175 out of 1274 females with CD2_BENIGN_TONSIL died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_TONSIL 1.917 [1.5, 2.46] < 0.001
Birth year 0.989 [0.98, 1.0] 0.016

During the follow-up period (1.1.1998 — 31.12.2019), 220 out of 943 males with CD2_BENIGN_TONSIL died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_TONSIL.

N-year risk Females Males
1 0.13% 0.355%
5 0.709% 2.208%
10 1.835% 5.227%
15 3.23% 10.463%
20 5.62% 18.211%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_TONSIL – Benign neoplasm: Tonsil

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data